- Presentations
- 4
- Markets
- 1
Coreg is a brand of Carvedilol marketed by Waylis Therapeutics, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Carvedilol
- Brand owner
- Waylis Therapeutics
- Registered in
- United States
- Strengths and forms
- 12.5 mg tablet, 25 mg tablet, 3.125 mg tablet, 6.25 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Coreg 12.5 mg tabletOral | Waylis Therapeutics | US FDA | Available on request |
| Coreg 25 mg tabletOral | Waylis Therapeutics | US FDA | Available on request |
| Coreg 3.125 mg tabletOral | Waylis Therapeutics | US FDA | Available on request |
| Coreg 6.25 mg tabletOral | Waylis Therapeutics | US FDA | Available on request |
Equivalent brands
Other brands of Carvedilol.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Coreg
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.